File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registry

TitleInsights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registry
Authors
Issue Date2012
PublisherExcerpta Medica, Inc.. The Journal's web site is located at http://www.ajconline.org/
Citation
The American Journal of Cardiology, 2012, v. 109 n. 3, p. 378-382 How to Cite?
AbstractThe burden of atrial fibrillation (AF) and the lack of data on AF and its management in the Asia Pacific highlight the need for a comprehensive prospective study of AF management in this region. To address this need, the REgistry on Cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) has been initiated to assess the management of AF in 8 countries across the Asia Pacific. RecordAF-AP is a prospective, observational survey of the management of recently diagnosed AF with 1 year of follow-up. Eligible patients with AF, treated or not, were included in the registry; with data recorded prospectively during the follow-up visits at 6 and 12 months. A total of 2,721 patients with AF were recruited, of whom 2,629 were eligible for evaluation (intent-to-treat population). At study inclusion, rhythm- and rate-control strategies were applied to 37% (n = 959) and 62% (n = 1,610) of the patients, respectively. At baseline, the rhythm-control patients were mainly prescribed class III agents (49%), class Ic agents (39%), or beta blockers (except for sotalol; 35%). The rate-control patients were mainly prescribed beta blockers (except for sotalol; 57%) or cardiac glycosides (32%). Patients receiving rate-control strategies were more likely to have a history of heart failure or valvular heart disease and persistent AF. In contrast, those receiving rhythm-control strategies were more likely to have recently diagnosed or paroxysmal AF. In conclusion, RecordAF-AP will provide much needed insight into the real-life management of patients with AF in the Asia Pacific region.
Persistent Identifierhttp://hdl.handle.net/10722/163446
ISSN
2015 Impact Factor: 3.154
2015 SCImago Journal Rankings: 2.063
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorAmerena, Jen_US
dc.contributor.authorChen, SAen_US
dc.contributor.authorSriratanasathavorn, Cen_US
dc.contributor.authorCho, JGen_US
dc.contributor.authorHuang, Den_US
dc.contributor.authorOmar, Ren_US
dc.contributor.authorTse, HFen_US
dc.contributor.authorKing, Aen_US
dc.date.accessioned2012-09-05T05:31:26Z-
dc.date.available2012-09-05T05:31:26Z-
dc.date.issued2012en_US
dc.identifier.citationThe American Journal of Cardiology, 2012, v. 109 n. 3, p. 378-382en_US
dc.identifier.issn0002-9149en_US
dc.identifier.urihttp://hdl.handle.net/10722/163446-
dc.description.abstractThe burden of atrial fibrillation (AF) and the lack of data on AF and its management in the Asia Pacific highlight the need for a comprehensive prospective study of AF management in this region. To address this need, the REgistry on Cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) has been initiated to assess the management of AF in 8 countries across the Asia Pacific. RecordAF-AP is a prospective, observational survey of the management of recently diagnosed AF with 1 year of follow-up. Eligible patients with AF, treated or not, were included in the registry; with data recorded prospectively during the follow-up visits at 6 and 12 months. A total of 2,721 patients with AF were recruited, of whom 2,629 were eligible for evaluation (intent-to-treat population). At study inclusion, rhythm- and rate-control strategies were applied to 37% (n = 959) and 62% (n = 1,610) of the patients, respectively. At baseline, the rhythm-control patients were mainly prescribed class III agents (49%), class Ic agents (39%), or beta blockers (except for sotalol; 35%). The rate-control patients were mainly prescribed beta blockers (except for sotalol; 57%) or cardiac glycosides (32%). Patients receiving rate-control strategies were more likely to have a history of heart failure or valvular heart disease and persistent AF. In contrast, those receiving rhythm-control strategies were more likely to have recently diagnosed or paroxysmal AF. In conclusion, RecordAF-AP will provide much needed insight into the real-life management of patients with AF in the Asia Pacific region.en_US
dc.languageengen_US
dc.publisherExcerpta Medica, Inc.. The Journal's web site is located at http://www.ajconline.org/en_US
dc.relation.ispartofThe American Journal of Cardiologyen_US
dc.subject.meshAnti-Arrhythmia Agents - therapeutic useen_US
dc.subject.meshAtrial Fibrillation - epidemiology - physiopathology - therapyen_US
dc.subject.meshCardiac Resynchronization Therapy - methodsen_US
dc.subject.meshHeart Rateen_US
dc.subject.meshRegistriesen_US
dc.titleInsights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registryen_US
dc.typeArticleen_US
dc.identifier.emailAmerena, J: johnam@barwonhealth.org.auen_US
dc.identifier.emailTse, HF: hftse@hkucc.hku.hk-
dc.identifier.authorityTse, HF=rp00428en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/j.amjcard.2011.08.046en_US
dc.identifier.pmid22118827-
dc.identifier.scopuseid_2-s2.0-84855968447en_US
dc.identifier.hkuros201295-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-84855968447&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume109en_US
dc.identifier.issue3en_US
dc.identifier.spage378en_US
dc.identifier.epage382en_US
dc.identifier.isiWOS:000300030400012-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridKing, A=7403373308en_US
dc.identifier.scopusauthoridTse, HF=7006070805en_US
dc.identifier.scopusauthoridOmar, R=16550973200en_US
dc.identifier.scopusauthoridHuang, D=7403891300en_US
dc.identifier.scopusauthoridCho, JG=54790557100en_US
dc.identifier.scopusauthoridSriratanasathavorn, C=35609047200en_US
dc.identifier.scopusauthoridChen, SA=39461009500en_US
dc.identifier.scopusauthoridAmerena, J=6603684781en_US
dc.identifier.citeulike10085013-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats